State regulators say the Oregon manufacturer Select, also known as Cura Cannabis, mixed up two lines of products at its Portland manufacturing site. A CBD product was not supposed to contain THC, but bottles sold contained high levels of the psychoactive ingredient associated with marijuana. A THC product was sold without sufficient doses of THC.
Cannabis manufacturer Select mixed up THC and CBD products, Oregon says, and that’s why unsuspecting consumers got high
State regulators say the Oregon manufacturer Select, also known as Cura Cannabis, evidently mixed up two lines of products at its Portland manufacturing site. A CBD product, at left, was not supposed to contain THC, but bottles sold contained high levels of the psychoactive ingredient associated with marijuana. A THC product, at right, was sold
CBD has over 500 drug interactions and side effects include liver damage and suicide risk. That is why FDA is stepping up warnings on CBD products. Consumer protection and Science is important. Visit the IASIC library to learn more about CBD and Drug interactions. Read the full article here: https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/cannafyl-611957-03012021
The U.S. Food and Drug Administration objected to an application from Charlotte’s Web Holdings Inc. for a CBD product to be sold as a dietary ingredient, leaving a cloud of uncertainty over the booming industry for the cannabis-derived substance. View the full article here: https://fortune.com/2021/08/11/fda-cbd-dietary-supplement-charlottes-web-holdings/ IASIC commends the FDA to sticking to science. While CBD
New York has banned delta 8. Should your community do the same? https://www.syracuse.com/marijuana/2021/05/new-york-bans-hot-new-cannabis-product-delta-8-striking-a-blow-to-some-cbd-retailers.html
All marijuana is cannabis, but not all cannabis is marijuana. See original post here May 10, 2021 by Laura Stack By Laura Stack At Johnny’s Ambassadors, we educate parents and teens about the dangers of today’s high-THC marijuana on adolescent brain development, mental illness, and suicide. Recently, Johnny’s Ambassadors has been asked about our usage of the
Most Recent News
Substance-related poisonings and injuries in Canada have received increasing attention in recent years due to emerging public health concerns, such as the opioid overdose crisis, the introduction of synthetic cannabinoids to the illicit market and the emergence of electronic cigarettes/vaping products on the Canadian market. Furthermore, there has been a general increase in substance-related hospitalizations
Changes in Rates of Hospitalizations due to Cannabis Harms in Ontario, Canada Before the Legalization of Nonmedical Cannabis: Retrospective Population-level Study Between 2003 and 2017
There are distinct patterns of hospitalizations due to cannabis harms in different priority populations. Young women aged 15 to 24 are a key demographic that is disproportionately burdened with a rapid increase in hospitalizations due to cannabis harms. Jurisdictions considering new approaches to cannabis control policy and addiction services should consider the rising burden of
Nonmedical (“recreational”) cannabis use and cannabis laws have changed over the past two decades in the United States (1) and the rest of the world (2). Increasing use, especially among the young, coupled with the increasing potency of cannabis (higher delta-9-tetrahydrocannabinol [THC] content) during this period (3), has raised concerns about the long-term health impact
IASIC Speaker Series Presents Where Does Cannabis Go in the Body and How It May Affect Teenagers’ Brain?
The International Academy on the Science and Impact of Cannabis (IASIC) is excited to present the IASIC Speaker Series. Presented free of charge, this ongoing educational seminar series will focus on the science, data and peer-reviewed research surrounding marijuana and will be led by international medical experts. This non-partisan and non-political series is continually developed,